More news at stockhouse on CHES
stockhouse.com
USA NETNOTES:
From: Others
Subject: CHES
LeRoy,
From: Bill S.
Company Name: Chester Holdings, Ltd. [CHES]
Closing Prices: 0.13
CHES, which was once just a shell looks to be getting some stuffing put into it. This could be a big winner for some getting in on the ground
floor. Many smart investors stayed away from this one because it was just a shell, but no longer. Daily average volume has picked up
tremendously on CHES and is attracting people to inquire within. Inactive since 1995 the company is in the midst of a reorganization and
expects to resume operations in the near future. Keep in mind that the company is still inactive as far as operations go.
The previous shareholders of this company have no rights to CHES as currently trading on the OTC-BB. There will be a new company filling
this shell.
The president of the company is Michael F. O'Shea. His background is accounting. The presidents vision is to acquire privately held companies
in the computer and pharmaceutical sector. So far O'Shea has hired Frohling Hudak & McCarthy to prepare the company for fully reporting
status in regulation with the SEC. CHES plans on becoming a fully reporting company by July/August time frame.
So far 3 companies are in negotiations with CHES. 1 pharmaceutical and 2 technical companies. The names of these companies in negotiations
were not given do to the Insider Trading law. 1 of the companies has revenues up to $90 million/year. This will be a tremendous holding for
CHES making its existing shares worth at least $1 in value. Of course the announcement of acquisitions will attract bigger investors. Keep in
mind that they are only in negotiations at this time.
CHES's last 2 PRs were forward looking and poses the excitement of a bright future.
The Gladstone Group, which currently provides disease state management programs to chain and independent pharmacies throughout the
United States, will support Chester Holdings in marketing the system. This proposed acquisition is one of several currently under consideration
by Chester.
CHES may secured $10 million worth of funding to aid in acquistions and reorganization.
After talking to the Attornies for CHES, it was found out that O'Shea was out of the country. Well it seems he was in Australia. Also a poster to
me from Australia previous to the announcement of Australian funding posted that he got a tip from a broker in Australia saying that CHES
would come into play. And that some Asains/Asian firm was looking into CHES.
CHES will obviously be into the online Pharmaceutical business. They are also looking to pick up some computer tech. companies. And since
the CHES is not operational at this time there is no way to say what the revenues will be. So far the revenues will be what ever Pharmaonline
brings, then added to that will be the revenues from the computer tech companies they bring in. Also what ever Gladstone brings into the deal.
Like I said if you don't own this stock then why are you still here?
Management is looking to bring active and profitable companies into this empty shell, the shell alone is worth big money since the SEC
tightened the restrictions on making companies eligible to list. Additionally, at this low stock price level and with the funding that they may get
in place they will be able to acquire something that will bring value to any new and existing shareholders along with a continued higher stock
price. Please review yesterdays News Release posted on Stockman's Forum.
Realistically the stock could see $1.00 or more in short term when Management announces exactly what they will be using the $10 million for. I'd
watch for something in a PR mid to late week. I believe that with $10 MM in funding and Press Releases coming soon this will lead to a sustain
stock rise with minor backing and filling.
Some points of recent interest:
- stock has gone through the accumulate / distribute, speculative period
- still a very speculative play
- float has been eaten up furiously
- more and more people have noticed CHES
- investors can still get in at a "reasonably" low price, and make yet a 4-5 bagger short term
- excellent momentum now
- Monday was a new high, support will then be in the .115-.13 range..
- low entry price and news is bringing a new and different dimension now to the stock. Sometimes you simply invest on the facts and the
different components you read and see coming together.
- Looks like pharmaonline.com has the potential to bring in some revenues from a "fee based system". Join our Club receive
discounts, Pharma news etc.. through a CO-OP style format and a nice cut I suppose on the meds & supplies. Check the site out as this is one
of the Companies that may reverse merge into CHES.
- CHES is involved with the Gladstone Group
gladstonegroup.com
Bottom Line For Me:
CHES by far has the most potential of any penny stock I've ever owned.
And Rememember:
Reading other people's opinions can only raise further questions. Confirm all yourself and then decide, always do your own Due Dilligence.
Good Profits All,
Regards Bill S.
From: Others
Subject: NYRR |
